INTERPACE BIOSCIENCES, INC. Proceeds from Lines of Credit
INTERPACE BIOSCIENCES, INC. (IDXG) reported Proceeds from Lines of Credit of $1.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2024-04-01
- INTERPACE BIOSCIENCES, INC. proceeds from lines of credit for the quarter ending 2022-12-31 was $0.00.
- INTERPACE BIOSCIENCES, INC. proceeds from lines of credit for the quarter ending 2022-09-30 was $0.00.
- INTERPACE BIOSCIENCES, INC. proceeds from lines of credit for the quarter ending 2022-06-30 was $0.00.
- INTERPACE BIOSCIENCES, INC. proceeds from lines of credit for the quarter ending 2022-03-31 was $1.00M.
- INTERPACE BIOSCIENCES, INC. proceeds from lines of credit for fiscal 2022 was $1.00M.
- INTERPACE BIOSCIENCES, INC. proceeds from lines of credit for fiscal 2019 was $3.00M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $1.00M 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $1.00M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.00M 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-16 | |||
| 2020-06-30 | $400.00K 10-Q/A · filed 2021-01-19 | |||
| 2019-12-31 | -$750.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-01-19 | $3.00M 10-K/A · filed 2021-01-19 | ||
| 2019-09-30 | $3.75M 10-Q · filed 2019-11-14 |